1-7 of 7
Young-Don Joo, MD, PhD
Close
Save search
Sort by
Journal Articles

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

Free
Il hwan Kim, MD, Young Don Joo, MD PhD, Joon Ho Moon, MD PhD, Sung Nam Lim, MD, Sang Kyun Sohn, MD PhD, Gyeong Won Lee, Ho Sup Lee, Ki Young Kwon, MD PhD, Sung Hyun Kim, Kyung Tae Park, Joo Seop Chung, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Myung Soo Hyun, MD PhD, Hawk Kim, Hun-Mo Ryoo, MD, Sung Hwa Bae
Journal: Blood
Blood (2014) 124 (21): 2676.
https://doi.org/10.1182/blood.V124.21.2676.2676
Published: 2014
Journal Articles

Inferior Long-Term Outcome of Front-Line Hypomethylating Agent Compared to Supportive Care in Patients with Lower Risk Myelodysplastic Syndrome: Prosensity Score Matched Analysis

Free
Sang Kyun Sohn, MD PhD, Joon Ho Moon, MD PhD, Ahn Jae Sook, MD, PhD, Hyeoung Joon Kim, MD PhD, Moo kon Song, MD, PhD, Ho-Jin Shin, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Young Don Joo, MD PhD, Ho Sup Lee, Yang Soo Kim, Yoon Young Cho, MD PhD, Sung Hwa Bae
Journal: Blood
Blood (2014) 124 (21): 3255.
https://doi.org/10.1182/blood.V124.21.3255.3255
Published: 2014
Journal Articles

Management of Patients After the Failure of Hypomethylating Treatment for Myelodysplastic Syndrome

Free
Je-Hwan Lee, MD, PhD, Jung-Hee Lee, Yunsuk Choi, MD, Dae-Young Kim, Kyoo-Hyung Lee, MD, Sang Min Lee, Won Sik Lee, Lee Jung-Lim, Young-Don Joo, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4953.
https://doi.org/10.1182/blood.V120.21.4953.4953
Published: 2012
Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia: An Interim Analysis

Free
Je-Hwan Lee, MD, PhD, Young-Don Joo, MD, PhD, Jung-Hee Lee, Hawk Kim, MD, Sung Hwa Bae, Min Kyung Kim, MD, Dae Young Zang, Jung-Lim Lee, Gyeong Won Lee, Won Sik Lee, Jae-Hoo Park, Dae-Young Kim, Sang Min Lee, Hun Mo Ryu, Myung Soo Hyun, Hyo Jung Kim, MD, PhD, Kyoo-Hyung Lee
Journal: Blood
Blood (2012) 120 (21): 3628.
https://doi.org/10.1182/blood.V120.21.3628.3628
Published: 2012
Journal Articles

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.

Free
Jae Hoon Lee, Junshik Hong, MD, Jin Seok Kim, June-Won Cheong, MD, Cheolwon Suh, MD, Kihyun Kim, MD, Yang Soo Kim, MD, Se-Ryeon Lee, MD, Sung Hwa Bae, Young-Don Joo, MD, PhD, Sang Min Lee, MD, Hyeon Seok Eom, MD, Eunkyung Park, MD, Sung-Soo Yoon, MD, PhD, Inho Kim, MD, PhD, Jae-Yong Kwak, MD, Chang-Ki Min, Jeong-A Kim, MD.PhD., Moo-Rim Park, MD, Sung Hyun Kim, MD, Hye Jin Kang, MD, Min Kyoung Kim, MD, Hawk Kim, MD, Yeung-Chul Mun, Hoon-Gu KIM, MD, Moon Hee Lee, MD
Journal: Blood
Blood (2012) 120 (21): 3106.
https://doi.org/10.1182/blood.V120.21.3106.3106
Published: 2012
Journal Articles

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Free
Kihyun Kim, Seok Jin Kim, MD, PhD, Byung Soo Kim, MD, PhD, Deog-Yeon Jo, MD, PhD, Hye Jin Kang, MD, Jin Seok Kim, M.D., Ph.D., Yeung-Chul Mun, Chul Soo Kim, MD, Sang Kyun Sohn, Hyeon Seok Eom, MD, PhD, Jae-Yong Kwak, Hyeok Shim, Hwi-Joong Yoon, Jong-Youl Jin, Chang-Ki Min, MD, Ho Jin Shin, Hyun Chun Shin, Jong-Ho Won, Je-Jung Lee, MD, PhD, Jung Hye Kwon, Young-Don Joo, MD, PhD, Young Rok Do, M.D., Sung Hyun Kim, Sukjoong Oh, MD, Cheolwon Suh, MD, Junglim Lee, Sung-Soo Yoon, Min Kyoung Kim, Soo-Mee Bang, Hun-Mo Ryoo, Bong-Seog Kim, Hawk Kim, MD, Hyo-Jung Kim, Yang Soo Kim, Chong Won Park, Gyeong-Won Lee, Seongkyu Park, Joon Seong Park, MD, Ho Young Kim, Dong Soon Lee, Jae Hoon Lee
Journal: Blood
Blood (2009) 114 (22): 4881.
https://doi.org/10.1182/blood.V114.22.4881.4881
Published: 2009
Journal Articles

Continuous Infusion of FLAG and Idarubicin for Patients Younger Than 60 Years with Resistant Acute Myeloid Leukemia; a Prospective, Multicenter Phase II Study.

Free
Hawk Kim, MD, PhD, Jae-Hoo Park, MD, PhD, Je-Hwan Lee, MD, PhD, Jung-Hee Lee, MD, PhD, Young-Don Joo, MD, PhD, Won-Sik Lee, MD, PhD, Sung-Hwa Bae, MD, PhD, Hun Mo Ryoo, MD, PhD, Kyoo-Hyung Lee, MD, PhD, Cooperative Study Group A for Hematology
Journal: Blood
Blood (2007) 110 (11): 4350.
https://doi.org/10.1182/blood.V110.11.4350.4350
Published: 2007